"My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South)
Refinement and Pilot Testing of the "My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions in the Deep South (MyHP-South)
The goal of this clinical trial is to evaluate the feasibility and acceptability of the revised My Health Priorities (MyHP) program among rural and underserved older adults with multiple chronic conditions in the Deep South. The program is designed to help participants clarify their health-related values, as well as improve communication with family caregivers and healthcare providers to support medical decision-making. The main question this study aims to answer is whether the revised MyHP program is practical/easy for individuals to use, and if it helps support necessary conversations about healthcare priorities. Participants will be asked to complete the revised MyHP program over a Zoom or in-person session with their caregiver, as well as complete questionnaires over a telephone interview before and 12 weeks after the completion of the program. In addition to participating in the MyHP program, caregivers will also be asked to complete a series of questionnaires over a telephone interview before and 12 weeks after the program. Both patients and caregivers will also be asked to complete a brief survey about their experience with the program over a telephone interview.
Обзор исследования
Статус
Статус
Условия
Условия
Вмешательство/лечение
Вмешательство/лечение
Тип исследования
Тип исследования
Регистрация (Оцененный)
Регистрация
Фаза
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
Контакты исследования
- Имя: Alexis M Johnson, B.S.
- Номер телефона: 205-975-1864
- Электронная почта: amjohns2@uab.edu
Учебное резервное копирование контактов
- Имя: Deborah B Ejem, Ph.D.
- Номер телефона: 205-996-1671
- Электронная почта: tejem@uab.edu
Места учебы
-
-
Alabama
-
Birmingham, Alabama, Соединенные Штаты, 35233
- The Whitaker Clinic of the University of Alabama at Birmingham (UAB) Hospital
-
Контакт:
- Alexis M Johnson, B.S.
- Номер телефона: 205-975-1864
- Электронная почта: amjohns2@uab.edu
-
Контакт:
- Deborah B Ejem, Ph.D.
- Номер телефона: 205-996-1671
- Электронная почта: tejem@uab.edu
-
-
Критерии участия
Критерии приемлемости
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria for Patients:
- Identifies as African American or White/Caucasian
- Is 65 years of age or older
- Has at least two of the following chronic conditions: cancer, heart disease, kidney disease, liver disease, or lung disease
- English-speaking and able to complete baseline study measures
- Cognitively able to participate in decision-making discussions
- Has a family caregiver that meets the eligibility requirements
- Has reliable telephone access
Inclusion Criteria for Caregivers:
- Identifies as African American or White/Caucasian
- Is 18 years of age or older
- A relative, partner, or friend who provides unpaid assistance or support with health-related decision-making (may or may not live in the same residence)
- English-speaking and able to complete baseline study measures
- Cognitively able to participate in decision-making discussions
- Has reliable telephone access
Exclusion Criteria for Patients:
- Has a documented diagnosis of dementia
- Is unable to understand the study and provide informed consent
- Resides in a nursing home or assisted living facility
Exclusion Criteria for Caregivers:
- Is unable to understand the study and provide informed consent
- Is unable to communicate with research staff
- Is unable to participate in the dyadic MyHP-South session and required assessments
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Исследования в области здравоохранения
- Распределение: Н/Д
- Интервенционная модель: Одногрупповое задание
- Маскировка: Нет (открытая этикетка)
Количество рук
Оружие и интервенции
Группа участников / АрмияГруппа участников / Армия |
Вмешательство/лечениеВмешательство/лечение |
|---|---|
|
Экспериментальный: MyHP-South Users
Includes the patients and caregivers who will be utilizing the MyHP-South program, as well as evaluating its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. This arm also includes the clinicians who will be assessing the usefulness of the program in a primary care setting. |
Participants will use the refined My Health Priorities South (MyHP-South) program to help identify and communicate personal health priorities, then evaluate its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. |
Что измеряет исследование?
Первичные показатели результатов
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Patient System Usability Scale (SUS)
Временное ограничение: At the MyHP-South session, within 14 days after baseline.
|
Over a Zoom or telephone interview, patients will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree. |
At the MyHP-South session, within 14 days after baseline.
|
|
Acceptability Interview
Временное ограничение: At the MyHP-South session, within 14 days after baseline.
|
Over a Zoom or telephone interview, both patients and caregivers will together answer 26 questions regarding their experience using the revised MyHP-South tool. Answer options will be open-ended. |
At the MyHP-South session, within 14 days after baseline.
|
|
Recruitment Feasibility
Временное ограничение: From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
|
Indicated by the number and proportion of eligible patient-caregiver dyads who enroll. |
From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
|
|
Retention and Completion Feasibility
Временное ограничение: From baseline through 12 weeks after the MyHP-South session.
|
Indicated by the number and proportion of enrolled dyads completing baseline assessments, the MyHP-South session, immediate post-session assessments, the acceptability interview, and the 12-week assessments. |
From baseline through 12 weeks after the MyHP-South session.
|
|
Caregiver System Usability Scale (SUS)
Временное ограничение: Immediately after the MyHP-South session, during the same study visit.
|
Over a Zoom or telephone interview, caregivers will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree. |
Immediately after the MyHP-South session, during the same study visit.
|
Вторичные показатели результатов
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
CollaboRATE Scale Score
Временное ограничение: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer three questions regarding their experience with their healthcare provider during a clinical encounter. Answer options will follow a ranked scale ranging from zero to nine and will then be calculated into a final score/percentage. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Treatment Burden Questionnaire (TBQ) Score
Временное ограничение: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer 13 questions regarding the potential burden of managing multiple chronic conditions. Answer options will follow a ranked scale ranging from zero to ten and will then be calculated into a final score. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Patient Shared Care Instrument Score
Временное ограничение: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer 19 questions regarding communication, decision making, and reciprocity with their caregiver. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Bakas Caregiver Outcomes Scale (BCOS)
Временное ограничение: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, caregivers will answer 10 questions regarding potential life changes that have occurred as a result of serving as a caregiver. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from -3: changed for the worse, to +3: changed for the best. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Older Patient Assessment of Chronic Illness Care (O-PACIC) Scale Score
Временное ограничение: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer ten questions regarding the quality of medical care they have received over the past six months. Answer options will follow a Likert-type frequency scale, which will then be calculated into a final score. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Caregiver Shared Care Instrument Score
Временное ограничение: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, caregivers will answer 19 questions regarding communication, decision making, and reciprocity with their patient. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales. |
At baseline and 12 weeks after the MyHP-South session.
|
Другие показатели результатов
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Timing Log for MyHP-South Session
Временное ограничение: At the MyHP-South session, within 14 days after baseline.
|
Research staff will document the length of each MyHP-South session by documenting what time the session started and what time the session ended. Time used to navigate technical difficulties will be subtracted. Tracking how long the session takes serves as a measure of feasibility. |
At the MyHP-South session, within 14 days after baseline.
|
|
Clinician Feedback Survey
Временное ограничение: Within 6 months after the completion of the MyHP-South session.
|
Over an electronic survey, clinicians who provide care to enrolled patients will answer ten questions regarding the clarity, fit, and usefulness of the revised MyHP-South in a primary care setting. |
Within 6 months after the completion of the MyHP-South session.
|
Соавторы и исследователи
Спонсор
Спонсор
Соавторы
Соавторы
Следователи
Следователи
- Главный следователь: Deborah B Ejem, Ph.D., University of Alabama at Birmingham
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Начало исследования
Первичное завершение (Оцененный)
Первичное завершение
Завершение исследования (Оцененный)
Завершение исследования
Даты регистрации исследования
Первый отправленный
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Первый опубликованный
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее опубликованное обновление
Последнее отправленное обновление, отвечающее критериям контроля качества
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
Другие идентификационные номера исследования
- IRB-300016725
- U54AG093230 (Грант/контракт NIH США)
- 606877 (Другой идентификатор: ASSIST Study ID)
- DGCG-11797 (Другой идентификатор: NIA CROMS Study ID)
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .